Bankruptcy filing worries developers of nanoparticle cancer drugs

Heidi Ledford

Nature, 2016, vol. 533, issue 7603, 304-305

Abstract: Financial woes of leading biotech firm highlight challenges of developing innovative therapies.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/533304a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:533:y:2016:i:7603:d:10.1038_533304a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/533304a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().